Sangamo Therapeutics, Inc. Profile Avatar - Palmy Investing

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The…

Biotechnology
US, Brisbane California [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SGMO's Analysis
CIK: 1001233 CUSIP: 800677106 ISIN: US8006771062 LEI: - UEI: -
Secondary Listings